Logistic regression analysis of prognostic factors in 106 acute-on-chronic liver failure patients with hepatic encephalopathy

Cui YanPing; Liu FengHua; Shi QingFeng; Zhao HongKui; Wang SiKui

doi:10.3969/j.issn.1001-5256.2014.10.005

Issue 10

Oct. 2014

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2014 > 30(10): 992-995

PDF( 1348 KB)

Logistic regression analysis of prognostic factors in 106 acute-on-chronic liver failure patients with hepatic encephalopathy

DOI: 10.3969/j.issn.1001-5256.2014.10.005

Liaocheng People's Hospital

Received Date: 2014-01-17
Published Date: 2014-10-20

Abstract

Abstract

Objective To analyze the prognostic factors in acute-on-chronic liver failure ( ACLF) patients with hepatic encephalopathy ( HE) and to explore the risk factors for prognosis. Methods A retrospective analysis was performed on106 ACLF patients with HE who were hospitalized in our hospital from January 2010 to July 2013. The patients were divided into improved group and deteriorated group. The univariate indicators including age, sex, laboratory indicators [total bilirubin ( TBil) , albumin ( Alb) , alanine aminotransferase ( ALT) , aspartate amino-transferase ( AST) , and prothrombin time activity ( PTA) ], the stage of HE, complications [persistent hyponatremia, digestive tract bleeding, hepatorenal syndrome ( HRS) , ascites, infection, and spontaneous bacterial peritonitis ( SBP) ], and plasma exchange were analyzed by chi-square test or t-test. Indicators with statistical significance were subsequently analyzed by binary logistic regression. Results Univariate analysis showed that ALT ( P = 0. 009) , PTA ( P = 0. 043) , the stage of HE ( P = 0. 000) , and HRS ( P = 0. 003) were significantly different between the two groups, whereas differences in age, sex, TBil, Alb, AST, persistent hyponatremia, digestive tract bleeding, ascites, infection, SBP, and plasma exchange were not statistically significant ( P >0. 05) . Binary logistic regression demonstrated that PTA ( b =-0. 097, P =0. 025, OR =0. 908) , HRS ( b =2. 279, P =0. 007, OR =9. 764) , and the stage of HE ( b = 1. 873, P = 0. 000, OR = 6. 510) were prognostic factors in ACLF patients with HE. Conclusion The stage of HE, HRS, and PTA are independent influential factors for the prognosis in ACLF patients with HE. Reduced PTA, advanced HE stage, and the presence of HRS indicate worse prognosis.
- liver failure,
- hepatic encephalopathy,
- logistic models

FullText(HTML)

References(15)

References

[1] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, MA;Severe Liver Diseases and Artificial Liver Group Chinese Society of Hepatology, MA.Guideline for diagnosis and treatment of liver failure (2012 version) [J].Chin J Clin Infect Dis, 2012, 12 (5) :321-326. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝治疗组、中华医学会肝病学分会重肝与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华临床感染病杂志, 2012, 12 (5) :321-326.

[2]Hepatic Encephalopathy Diagnosis and Treatment of the Expert Committee.Expert consensus on diagnosis and treatment of hepatic encephalopathy[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2009, 3 (4) :449-473. (in Chinese) 肝性脑病诊断治疗专家委员会.肝性脑病诊断治疗专家共识[J/CD].中华实验和临床感染病杂志:电子版, 2009, 3 (4) :449-473.

[3]FICHET J, MERCIER E, GENE O, et al.Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy[J].J Crit Care, 2009, 24 (3) :364-370.

[4]XIE SB, WU YK, ZHU JY, et al.Establishment and evaluation of prognosis scoring system for acute-on-chronic liver failure[J].J Sun Yat-sen univ:Medical Sciences, 2011, 32 (6) :834-840. (in Chinese) 谢仕斌, 吴元凯, 朱建芸, 等.慢加急性肝衰竭预后评分系统的建立与评估[J].中山大学学报:医学科学版, 2011, 32 (6) :834-840.

[5]LIU XY, CHEN J, WANG XX, et al.Etiological analysis of 3233patients with acute liver failure, subacute liver failure and acuteon-chronic liver failure[J].Clin Med Engineering, 2012, 19 (5) :823-825. (in Chinese) 刘晓燕, 陈婧, 王晓霞, 等.3233例急性、亚急性、慢加急性肝衰竭病因特点分析[J].临床医学工程, 2012, 19 (5) :823-825.

[6] LIU XY, HU JH, WANG HF, et al.Etiological analysis of 1977 patients with acute liver failure, subacute liver failure and acute-onchronic liver failure[J].Chin J Hepatol, 2008, 16 (10) :772-775. (in Chinese) 刘晓燕, 胡瑾华, 王慧芬, 等.1977例急性、亚急性、慢加急性肝衰竭患者的病因与转归分析[J].中华肝脏病杂志, 2008, 16 (10) :772-775.

[7]ZENG Z, LOU M, CHANG XJ, et al.Clinical characteristics and prognosis of four types of liver failure[J].Infect Dis Info, 2008, 21 (6) :353-354. (in Chinese) 曾珍, 楼敏, 常秀娟, 等.四类肝衰竭的临床特点与转归分析[J].传染病信息, 2008, 21 (6) :353-354.

[8]YU YH, JIANG JN, WU JZ, et al.Logistic regression analysis of prognostic factors for hepatic encephalopathy[J].Chin J Infect Dis, 2009, 27 (5) :305-307. (in Chinese) 玉艳红, 江建宁, 吴继周, 等.肝性脑病患者预后影响因素的Logistic回归分析[J].中华传染病杂志, 2009, 27 (5) :305-307.

[9]TAO C, YUAN CB, ZENG WQ, et al.Analysis of causes of death in 72 patients with chronic severe hepatitis[J].Chin J Primary Med Pharm, 2008, 15 (9) :1497-1498. (in Chinese) 陶晨, 袁春蓓, 曾文权, 等.慢性重型肝炎72例死亡原因分析[J].中国基层医药, 2008, 15 (9) :1497-1498.

[10]YE PY, YANG ZG, CHEN XR, et al.Risk factors associated with prognosis of progressive stages of acute-on-chronic hepatitis B liver failure[J].J Clin Hepatol, 2013, 29 (4) :270-275. (in Chinese) 叶佩燕, 杨宗国, 陈晓蓉, 等.HBV相关慢加急性肝衰竭不同分期的预后评价及影响因素分析[J].临床肝胆病杂志, 2013, 29 (4) :270-275.

[11]YANG B, WU YK, CHEN ZC, et al.The dynamic changes of ALT, AST, TBil and PT and their relationship with prognosis of acute-on-chronic hepatitis B liver failure[J].J Clin Hepatol, 2012, 28 (3) :205-208. (in Chinese) 杨波, 吴元凯, 陈忠诚, 等.ALT、AST、TBil及PT变化趋势与慢加急性乙型肝炎肝衰竭预后的关系[J].临床肝胆病杂志, 2012, 28 (3) :205-208.

[12] LIU XY, HU JH, WANG HF, et al.Analysis of prognostic factors for patients with acute-on-chronic liver failure[J].Chin J Hepatol, 2009, 17 (8) :607-610. (in Chinese) 刘晓燕, 胡瑾华, 王慧芬, 等.乙型肝炎病毒感染所致慢加急肝衰竭的临床预后分析[J].中华肝脏病杂志, 2009, 17 (8) :607-610.

[13]LAI N, GUO SH, ZHANG DZ, et al.A single factor analysis of the prognosis of 301 hepatitis failure cases and a study of a scoring system on their prognostic assessment[J].Chin J Hepatol, 2005, 13 (8) :586-589. (in Chinese) 赖宁, 郭树华, 张大志, 等.重型肝炎预后单因素分析与预后评估系统研究[J].中华肝脏病杂志, 2005, 13 (8) :586-589.

[14]SUN LH, ZHANG YX, XIAO L, et al.Analysis of the prognosis of severe hepatitis treated with molecular adsorbent recycling system (MARS) using MELD score[J].Chin J Hepatol, 2005, 13 (8) :632-635. (in Chinese) 孙丽华, 张跃新, 肖琳, 等.终末期肝病评分模型评价分子吸附再循环系统治疗重型肝炎的疗效和预后[J].中华肝脏病杂志, 2005, 13 (8) :632-635.

[15]LIAO JM, LI ZR, HU XX.The therapeutic effect of plasma exchange therapy in patients with severe hepatitis[J].J Clin Hepatol, 2012, 28 (4) :302-304. (in Chinese) 廖金卯, 李灼日, 胡小宣.人工肝血浆置换治疗重型肝炎的疗效观察[J].临床肝胆病杂志, 2012, 28 (4) :302-304.

Relative Articles

[1]	Shuaixia FENG, Ying XU, Han HAN. Role and potential significance of peroxisome proliferator-activated receptors in liver diseases[J]. Journal of Clinical Hepatology, 2023, 39(7): 1747-1753. doi: 10.3969/j.issn.1001-5256.2023.07.034
[2]	Jiahe ZHAO, Xinyu MA, Jingya XU, Tingting DUAN, Chunlei ZHANG, Baolong LI. Research advances in related factors for autophagy in the regulation of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(7): 1713-1717. doi: 10.3969/j.issn.1001-5256.2021.07.050
[3]	Li WenMi, Wang Nan, Bian Qian, Huang Qian, Li JingTao, Wei HaiLiang, Yan ShuGuang. Role of liver X receptor in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(10): 2349-2352. doi: 10.3969/j.issn.1001-5256.2020.10.041
[4]	Chen YiYan, Lu Yan. Application of nuclear receptor in pathogenesis research and drug development for nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(6): 1221-1223. doi: 10.3969/j.issn.1001-5256.2020.06.006
[5]	Ren Shan, Du XiaoFei, Huang YunLi, Huang ChunYang, Zhang XiaoDan, Dan Jing, Chen XinYue. Serum interferon-gamma-induced protein-10 level and gene polymorphism in patients with drug-induced liver injury accompanied by autoimmune phenomena[J]. Journal of Clinical Hepatology, 2020, 36(3): 602-607. doi: 10.3969/j.issn.1001-5256.2020.03.026
[6]	A RuHan, Jia HaiYan, Ding YanHua, Niu JunQi. Research advances in nonalcoholic fatty liver disease in lean individuals[J]. Journal of Clinical Hepatology, 2020, 36(5): 1154-1159. doi: 10.3969/j.issn.1001-5256.2020.05.046
[7]	Chu PeiLing, Wang Qi, Guo XiaoQing, Liu JinChun. Association between chemokines and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2019, 35(7): 1626-1628. doi: 10.3969/j.issn.1001-5256.2019.07.044
[8]	Ou WeiJie, Lin YeHong, Zhou Qing, Shang TianYu, Lin Su, Zhu YueYong. Association of vitamin D-related gene polymorphisms with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2019, 35(6): 1308-1312. doi: 10.3969/j.issn.1001-5256.2019.06.025
[9]	Liu Qun, Luan GuiPing, Gao Hui, Zhao BenTian, Du ShuiXian, Liu ShouSheng, Xin YongNing. Association of TRIB1 rs2954029 single nucleotide polymorphism with the risk of nonalcoholic fatty liver disease and coronary heart disease[J]. Journal of Clinical Hepatology, 2019, 35(6): 1330-1336. doi: 10.3969/j.issn.1001-5256.2019.06.030
[10]	Zhou Fan, Peng JunWei, Fan FuGang, Jiang YuanYe, Cao Qin. Interrelation between autophagy and oxidative stress in pathogenesis of nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2018, 34(8): 1805-1808. doi: 10.3969/j.issn.1001-5256.2018.08.048
[12]	Liao SongLing, Liu ShouSheng, Wang Cong, Chen LiZhen, Xin YongNing, Xuan ShiYing. Association between MBOAT7 rs641738 polymorphism and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2018, 34(10): 2169-2174. doi: 10.3969/j.issn.1001-5256.2018.10.021
[13]	Yue HaiYan, Liu ShouSheng, Wang Cong, Gu JiuLian, Xin YongNing, Xuan ShiYing. Association between single nucleotide polymorphism of low-density lipoprotein receptor and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2018, 34(9): 1929-1935. doi: 10.3969/j.issn.1001-5256.2018.09.021
[14]	Zhang Hua, He DeHua, Li GuiZhong. Association between single nucleotide polymorphism of microRNA-146a and recurrence after liver cancer surgery[J]. Journal of Clinical Hepatology, 2016, 32(5): 904-907. doi: 10.3969/j.issn.1001-5256.2016.05.018
[15]	Liu Yang, Jiang Man, Chen LiZhen, Du ShuiXian, Xin YongNing, Xuan ShiYing. Association between AGTR1 gene polymorphism and risk of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2015, 31(7): 1082-1087. doi: 10.3969/j.issn.1001-5256.2015.07.020
[16]	Xu Xin, Jiang Man, Li JiangWen, Dong QuanYong, Lin ZhongHua, Chu LeiLei, Xin YongNing, Xuan ShiYing. Association between PPARγ gene rs3856806 polymorphism and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2015, 31(7): 1088-1091. doi: 10.3969/j.issn.1001-5256.2015.07.021
[17]	Xin Xuan, Yan HongZhu, Li WeiQing, Yu HongYu. Studies on PPAR α and γ participating in progression of liver fibrosis by regulating ACSL1[J]. Journal of Clinical Hepatology, 2014, 30(7): 700-702. doi: 10.3969/j.issn.1001-5256.2014.07.034
[18]	Xin Xuan, Yan HongZhu, Li WeiQing, Yu HongYu. Studies on PPAR α and γ participating in progression of liver fibrosis by regulating ACSL1[J]. Journal of Clinical Hepatology, 2014, 30(8): 833-835. doi: 10.3969/j.issn.1001-5256.2014.08.038
[19]	Niu TongHong, Zhang Mei, Jiang Man, Xin YongNing, Xuan ShiYing. Research advances in gene polymorphisms in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2013, 29(12): 947-951. doi: 10.3969/j.issn.1001-5256.2013.12.020
[20]	Shen Bo, Nie YuQiang. Peroxisome proliferator- activated receptor gamma inhibits liver cancer proliferation and metastasis in vitro[J]. Journal of Clinical Hepatology, 2013, 29(9): 702-706. doi: 10.3969/j.issn.1001-5256.2013.09.018

Supplements(0)

Cited By

Cited by

Periodical cited type(7)

1.	季丹. 凝血酶原时间与血小板检测对肝硬化患者诊断的临床意义. 人人健康. 2020(08): 263 .
2.	何搏，张春清. 卡维地洛治疗肝硬化门静脉高压症的作用机制及应用现状. 临床肝胆病杂志. 2019(02): 399-401 . 本站查看
3.	文政伟，李秋兰，何均辉. 慢性乙型肝炎患者抗病毒治疗后肝纤维化动态变化的定性评估. 中国肝脏病杂志(电子版). 2019(01): 77-80 .
4.	曹海丹，黄寅，罗晓蓉，吴县斌. 卡维地洛与普萘洛尔治疗肝硬化门静脉高压的临床疗效及不良反应的对照研究. 北方药学. 2019(11): 138-140 .
5.	高云飞，高凤成，李清峰，马强，邢通潮，杜婷婷. 原发性肝细胞癌患者TACE治疗前后血清血小板源性生长因子-BB水平变化及其临床意义. 现代检验医学杂志. 2019(06): 73-76 .
6.	由淑萍，张石蕾，赵军，马龙，刘涛. 毛蕊花糖苷对血小板衍生生长因子BB处理后大鼠肝星状细胞的影响. 癌变·畸变·突变. 2018(06): 473-478 .
7.	汤伟伟，何永文. PDGF-BB/PDGFR-β与肿瘤发生发展的研究进展. 临床与病理杂志. 2017(11): 2457-2462 .

Other cited types(7)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3005) PDF downloads(683)

Logistic regression analysis of prognostic factors in 106 acute-on-chronic liver failure patients with hepatic encephalopathy

DOI: 10.3969/j.issn.1001-5256.2014.10.005